How should I manage a patient with greater than 70% stenosis of the left internal carotid artery and less than 50% stenosis of the right internal carotid artery?

Management of >70% Left Internal Carotid Artery Stenosis with <50% Right Internal Carotid Artery Stenosis

This patient requires urgent evaluation by a multidisciplinary stroke team for carotid endarterectomy (CEA) of the left internal carotid artery, which should be performed within 14 days if symptomatic, combined with intensive medical therapy regardless of whether revascularization is performed. 1

Immediate Assessment Required

The critical first step is determining whether this patient is symptomatic or asymptomatic for the left-sided stenosis:

• Symptomatic = Recent stroke, TIA, or amaurosis fugax in the past 6 months ipsilateral to the left carotid stenosis
• Asymptomatic = No neurological symptoms attributable to the left carotid territory

This distinction fundamentally changes management, as symptomatic patients have substantially higher stroke risk and derive greater benefit from revascularization.

Management Algorithm for Left-Sided 70-99% Stenosis

If SYMPTOMATIC (stroke/TIA within past 6 months):

Carotid endarterectomy is strongly recommended provided the surgical team's perioperative morbidity/mortality risk is <6% 1, 2. The evidence is unequivocal here:

• Timing is critical: CEA should be performed within 14 days of symptom onset, ideally within the first few days if the patient is clinically stable 1, 2
• CEA is preferred over carotid artery stenting (CAS) in most patients 1
• CAS may be considered only if the patient is NOT a surgical candidate due to technical, anatomic, or medical contraindications 1
• For patients <70 years old, CAS may be considered as an alternative if performed by experienced operators with documented perioperative stroke/death rates <6% 2

The 2024 ESC guidelines 2 provide the most recent high-quality evidence, confirming that symptomatic 70-99% stenosis warrants CEA (Class I, Level A recommendation) with surgery within 14 days (Class I, Level B).

If ASYMPTOMATIC:

The management is more nuanced and controversial. Medical therapy alone may be reasonable given modern advances in stroke prevention, but revascularization can be considered in highly selected patients 1, 3:

• CEA may be considered if the patient has >70% stenosis, life expectancy >5 years, and perioperative risk <3% 3, 4
• The 2024 ESC guidelines 2 state that in asymptomatic patients without high-risk features and life expectancy <5 years, routine revascularization is NOT recommended (Class III, Level A)
• Patient-specific factors must guide decision-making: age, sex, comorbidities, and plaque characteristics 1

Important caveat: The benefit of CEA in asymptomatic patients has diminished substantially with modern medical therapy. The absolute stroke risk reduction is small (approximately 1% per year), and ongoing trials (CREST-2) are reassessing whether revascularization adds benefit over contemporary medical management 5, 6, 7.

Intensive Medical Therapy (MANDATORY for ALL patients)

Regardless of whether revascularization is performed, all patients with carotid stenosis require aggressive medical management 1, 2:

Antiplatelet Therapy:

• Symptomatic patients not undergoing immediate revascularization: Dual antiplatelet therapy (DAPT) with aspirin 75-100 mg + clopidogrel 75 mg for the first 21 days, then long-term single antiplatelet (clopidogrel preferred) 2
• Asymptomatic patients: Aspirin 75-325 mg daily OR clopidogrel 75 mg daily 8, 3
• After CEA: Aspirin 75-325 mg daily perioperatively and continued indefinitely 8, 2
• After CAS: DAPT (aspirin + clopidogrel) for at least 1 month, then long-term single antiplatelet 2

Lipid Management:

• High-intensity statin therapy targeting LDL-C <1.4 mmol/L (55 mg/dL) with >50% reduction from baseline 2
• This represents intensive lipid-lowering therapy (ILT) per 2024 ESC guidelines

Blood Pressure Control:

• Target <140/90 mmHg (general population) 1
• Careful perioperative BP management is critical to prevent post-CEA complications 2

Additional Risk Factor Management:

• Diabetes control (consider SGLT2 inhibitors or GLP-1 receptor agonists for CV benefits) 9
• Smoking cessation with pharmacologic support if needed 1
• Mediterranean-style diet and regular exercise 1, 9

Management of Right-Sided <50% Stenosis

No revascularization is indicated for stenosis <50% 1, 8, 2. This is a Class III (no benefit) recommendation with Level A evidence.

The right carotid requires:

• Same intensive medical therapy as outlined above
• Annual surveillance with duplex ultrasound to monitor progression 2, 3
• Reassessment if stenosis progresses to ≥50% or if symptoms develop

Common Pitfalls to Avoid

1. Delaying surgery in symptomatic patients: The benefit of CEA diminishes rapidly with time. Surgery beyond 14 days loses much of its protective effect 1, 2

2. Performing revascularization with high perioperative risk: If the surgical team's stroke/death rate exceeds 6% for symptomatic patients (or 3% for asymptomatic), medical therapy alone is superior 1, 2

3. Assuming all asymptomatic patients need surgery: Modern medical therapy has dramatically reduced stroke risk. Routine revascularization in asymptomatic patients without high-risk features is not recommended 2

4. Neglecting medical therapy after revascularization: Intensive medical management is mandatory regardless of intervention, as it addresses systemic atherosclerosis and prevents contralateral disease progression 1, 2

5. Using CAS routinely in elderly patients: CEA is preferred over CAS, particularly in patients >70 years old, due to higher periprocedural stroke risk with stenting in this age group 1, 10

Follow-Up Strategy

• Post-revascularization: Duplex ultrasound within the first month, then annually 2
• Annual assessment of neurological symptoms, cardiovascular risk factors, and medication adherence 2
• Surveillance imaging of the contralateral (right) carotid to detect progression 3